CAS No. |
146978-48-5 |
|---|---|
中文名称 |
莫昔鲁班特 |
英文名称 |
Moxilubant |
别名 |
Moxilubant;Moxilubant [inn];Benzamide, 4-[[5-[4-(aminoiminomethyl)phenoxy]pentyl]oxy]-3-methoxy-N,N-bis(1-methylethyl)-;4-[5-(4-carbamimidoylphenoxy)pentoxy]-3-methoxy-N,N-di(propan-2-yl)benzamide |
标准英文名 |
4-((5-(4-carbamimidoylphenoxy)pentyl)oxy)-N,N-diisopropyl-3-methoxybenzamide |
MDL No. |
MFCD00917370 |
分子式 |
C26H37N3O4 |
分子量 |
455.60 |
精确分子量 |
455.28 |
SMILES |
O=C(C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(=N)N)C(OC)=C1)N(C(C)C)C(C)C |
标准SMILES |
COC1=CC(=CC=C1OCCCCCOC1C=CC(=CC=1)C(N)=N)C(=O)N(C(C)C)C(C)C |
用途 |
Moxilubant is an orally active BLT1 antagonist that inhibits LTB4 signaling with a potency of 2–4 nM; it can be used in cancer research. |
InChIKey |
VAYJLOGCWOXMAS-UHFFFAOYSA-N |
|
|
评论 |
|---|